These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Augmentation and combination strategies in treatment-resistant depression. Fava M J Clin Psychiatry; 2001; 62 Suppl 18():4-11. PubMed ID: 11575733 [TBL] [Abstract][Full Text] [Related]
3. Combining antidepressants for treatment-resistant depression: a review. Lam RW; Wan DD; Cohen NL; Kennedy SH J Clin Psychiatry; 2002 Aug; 63(8):685-93. PubMed ID: 12197448 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological strategies in treatment-resistant depression. Alao AO; Malhotra K; Pies R; Dewan MJ West Afr J Med; 2003 Sep; 22(3):211-8. PubMed ID: 14696943 [TBL] [Abstract][Full Text] [Related]
5. Treatment of antidepressant nonresponders: augmentation or switch? Nelson JC J Clin Psychiatry; 1998; 59 Suppl 15():35-41. PubMed ID: 9786309 [TBL] [Abstract][Full Text] [Related]
6. Management of nonresponse and intolerance: switching strategies. Fava M J Clin Psychiatry; 2000; 61 Suppl 2():10-2. PubMed ID: 10714618 [TBL] [Abstract][Full Text] [Related]
7. Drugs for depression. Med Lett Drugs Ther; 2016 Jul; 58(1498):85-90. PubMed ID: 27348144 [No Abstract] [Full Text] [Related]
8. Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study. Parker G; Roy K; Wilhelm K; Mitchell P J Clin Psychiatry; 2001 Feb; 62(2):117-25. PubMed ID: 11247097 [TBL] [Abstract][Full Text] [Related]
9. Rational drug use in the treatment of depression. Cohen LJ Pharmacotherapy; 1997; 17(1):45-61. PubMed ID: 9017765 [TBL] [Abstract][Full Text] [Related]
11. Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs. DeBattista C; Sofuoglu M; Schatzberg AF Biol Psychiatry; 1998 Sep; 44(5):341-7. PubMed ID: 9755356 [TBL] [Abstract][Full Text] [Related]
16. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. Papakostas GI J Clin Psychiatry; 2009; 70 Suppl 6():16-25. PubMed ID: 19922740 [TBL] [Abstract][Full Text] [Related]
17. Switching drug class after initial SSRI failure. Kelsey JE J Clin Psychiatry; 1997 Jul; 58(7):326-7. PubMed ID: 9269258 [No Abstract] [Full Text] [Related]
18. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Thomas SJ; Shin M; McInnis MG; Bostwick JR Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531 [TBL] [Abstract][Full Text] [Related]
19. [Combining antidepressants: a useful strategy for therapy resistant depression?]. Schmauss M; Messer T Fortschr Neurol Psychiatr; 2009 Jun; 77(6):316-25. PubMed ID: 19415584 [TBL] [Abstract][Full Text] [Related]